Back to search

Article

Comparative effectiveness of sulfadoxine–pyrimethamine plus amodiaquine versus other antimalarial regimens for paediatric malaria chemoprevention in the context of drug resistance: a systematic review and meta-analysis

2026-07-17

Abstract excerpt

<h4>Summary</h4> Each year, over 50 million children receive preventive malaria treatment. However, to date there has been no consensus on the most effective antimalarial drugs to use, especially given geographic differences in drug resistance. Here, we conduct a systematic review comparing the effectiveness of the most commonly used antimalarial chemopreventive regimen, sulfadoxine-pyrimethamine plus amodiaquine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
10b31151-2403-5a73-9b32-ac848be4df6d
DOI
10.64898/2026.07.16.26356047
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative effectiveness of sulfadoxine–pyrimethamine plus amodiaquine versus other antimalarial regimens for paediatric malaria chemoprevention in the context of drug resistance: a systematic review and meta-analysisDOI 10.64898/2026.07.16.26356047
Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern UgandaSemantic proximity
Prevalence of Molecular Markers of Resistance to Antimalarial Drugs Three Years After Perennial Malaria Chemoprevention in Sierra LeoneSemantic proximity
Rethinking a hybrid malaria chemoprevention delivery strategy for children in sub-perennial settings: integrating age- and seasonally-targeted deliverySemantic proximity
Regional Patterns and Temporal Trends of Pfdhfr and Pfdhps Markers of Antifolate Resistance in Plasmodium falciparum in East and West Africa, 2010-2025: A Systematic Review.Semantic proximity
Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling studySemantic proximity
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in ZambiaSemantic proximity
Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022.Semantic proximity
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trialSemantic proximity
Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling study.Semantic proximity
Seasonal malaria chemoprevention and the spread of<i>Plasmodium falciparum</i>quintuple mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling studySemantic proximity
Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in MaliSemantic proximity
Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South SudanSemantic proximity
Select a neighboring publication to make it the new centre.